WO2002094867A3 - Sequence du genome de photorhabdus luminescens souche tto1 et utilisations - Google Patents

Sequence du genome de photorhabdus luminescens souche tto1 et utilisations Download PDF

Info

Publication number
WO2002094867A3
WO2002094867A3 PCT/IB2002/003040 IB0203040W WO02094867A3 WO 2002094867 A3 WO2002094867 A3 WO 2002094867A3 IB 0203040 W IB0203040 W IB 0203040W WO 02094867 A3 WO02094867 A3 WO 02094867A3
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
genome
photorhabdus luminescens
polypeptides
vectors
Prior art date
Application number
PCT/IB2002/003040
Other languages
English (en)
Other versions
WO2002094867A2 (fr
WO2002094867A8 (fr
Inventor
Eric Duchaud
Sead Taourit
Philippe Glaser
Lionel Frangeul
Frederik Kunst
Antoine Danchin
Carmen Buchrieser
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Eric Duchaud
Sead Taourit
Philippe Glaser
Lionel Frangeul
Frederik Kunst
Antoine Danchin
Carmen Buchrieser
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient, Eric Duchaud, Sead Taourit, Philippe Glaser, Lionel Frangeul, Frederik Kunst, Antoine Danchin, Carmen Buchrieser filed Critical Pasteur Institut
Priority to US10/467,478 priority Critical patent/US20070020625A1/en
Priority to AU2002339119A priority patent/AU2002339119A1/en
Priority to CA002434323A priority patent/CA2434323A1/fr
Priority to EP20020751498 priority patent/EP1379549A2/fr
Priority to KR10-2003-7010403A priority patent/KR20030085528A/ko
Publication of WO2002094867A2 publication Critical patent/WO2002094867A2/fr
Publication of WO2002094867A8 publication Critical patent/WO2002094867A8/fr
Publication of WO2002094867A3 publication Critical patent/WO2002094867A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'invention a pour objet la séquence génomique et des séquences nucléotidiques codant pour des polypeptides de Photorhabdus luminescens, tels que des polypeptides impliqués dans des opérons de biosynthèse d'antibiotiques, ou de toxines, ou des polypeptides à activité de type toxine ou antibiotique pouvant être utilisés comme pesticide, bactéricide ou fongicide ainsi que des vecteurs incluant lesdites séquences et des cellules ou animaux transformés par ces vecteurs.
PCT/IB2002/003040 2001-02-07 2002-02-07 Sequence du genome de photorhabdus luminescens souche tto1 et utilisations WO2002094867A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US10/467,478 US20070020625A1 (en) 2001-02-07 2002-02-07 Sequence of the photorhabdus luminescens strain tt01 genome and uses
AU2002339119A AU2002339119A1 (en) 2001-02-07 2002-02-07 Sequence of the photorhabdus luminescens strain tt01 genome and uses
CA002434323A CA2434323A1 (fr) 2001-02-07 2002-02-07 Sequence du genome de photorhabdus luminescens souche tto1 et utilisations
EP20020751498 EP1379549A2 (fr) 2001-02-07 2002-02-07 Sequence du genome de photorhabdus luminescens souche tto1 et utilisations
KR10-2003-7010403A KR20030085528A (ko) 2001-02-07 2002-02-07 포토랍두스 루미네센스 균주 ｔｔ01 게놈 및 그 용도

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0101659 2001-02-07
FR0101659 2001-02-07

Publications (3)

Publication Number Publication Date
WO2002094867A2 WO2002094867A2 (fr) 2002-11-28
WO2002094867A8 WO2002094867A8 (fr) 2003-01-23
WO2002094867A3 true WO2002094867A3 (fr) 2003-11-13

Family

ID=8859730

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/003040 WO2002094867A2 (fr) 2001-02-07 2002-02-07 Sequence du genome de photorhabdus luminescens souche tto1 et utilisations

Country Status (6)

Country Link
US (1) US20070020625A1 (fr)
EP (1) EP1379549A2 (fr)
KR (1) KR20030085528A (fr)
AU (1) AU2002339119A1 (fr)
CA (1) CA2434323A1 (fr)
WO (1) WO2002094867A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20026285D0 (no) * 2002-12-30 2002-12-30 Amersham Health As Nye peptider
AR042717A1 (es) 2003-01-21 2005-06-29 Dow Agrosciences Llc Proteinas de tc de xenorhabdus y genes para el control de plagas
BRPI0406856A (pt) 2003-01-21 2005-12-27 Dow Agrosciences Llc Mistura e compatibilidade de proteìnas de tc para controle de peste
US20080113917A1 (en) * 2003-11-06 2008-05-15 Day Anthony G Tgfbeta Supported and Binding Peptides
AU2005218598A1 (en) * 2004-03-02 2005-09-15 Dow Agrosciences Llc Insecticidal toxin complex fusion proteins
JP2008537878A (ja) 2005-03-18 2008-10-02 マイクロビア， インコーポレイテッド 含油性酵母および真菌におけるカロテノイドの産生
WO2006123157A2 (fr) * 2005-05-18 2006-11-23 University Of Bath Proteine nematistatique
US8691555B2 (en) 2006-09-28 2014-04-08 Dsm Ip Assests B.V. Production of carotenoids in oleaginous yeast and fungi
EP2234632B1 (fr) * 2008-01-10 2014-10-29 Endocrine Pharmaceuticals Limited Composés protéinés
AT506535B1 (de) * 2008-02-22 2010-04-15 Affiris Forschungs & Entwicklungs Gmbh Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden
AU2008355461B2 (en) 2008-04-24 2015-07-30 Newsouth Innovations Pty Limited Cyanobacteria saxitoxin gene cluster and detection of cyanotoxic organisms
WO2010002876A2 (fr) * 2008-06-30 2010-01-07 Monsanto Technology Llc Compositions et procédés permettant de renforcer les niveaux d'acides aminés dans les plantes
UA112050C2 (uk) * 2008-08-04 2016-07-25 БАЄР ХЕЛСКЕР ЛЛСі Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi)
US9085798B2 (en) 2009-04-30 2015-07-21 Prognosys Biosciences, Inc. Nucleic acid constructs and methods of use
EP2277989A1 (fr) 2009-07-24 2011-01-26 Technische Universiteit Delft Production d'éthanol dépourvu de glycérol par fermentation
CA2976671C (fr) 2010-03-01 2021-01-12 Bayer Healthcare Llc Optimisation d'anticorps monoclonaux diriges contre l'inhibiteur de la voie du facteur tissulaire (tfpi)
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
WO2011127099A1 (fr) 2010-04-05 2011-10-13 Prognosys Biosciences, Inc. Tests biologiques à codage spatial
WO2012139110A2 (fr) * 2011-04-08 2012-10-11 Prognosys Biosciences, Inc. Constructions peptidiques et systèmes d'essai
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
WO2013065302A1 (fr) * 2011-11-01 2013-05-10 独立行政法人産業技術総合研究所 Procédé de détection de cellules indifférenciées et procédé de détection d'hydrate de carbone complexe
KR101246707B1 (ko) * 2012-08-01 2013-03-25 ㈜엠알이노베이션 포토랍두스 템프라타 템프라타 균주를 포함하는 뿌리혹선충 방제용 조성물
WO2014145047A1 (fr) 2013-03-15 2014-09-18 Prognosys Biosciences, Inc. Procédés de détection de liaison peptide/mhc/tcr
WO2014210225A1 (fr) 2013-06-25 2014-12-31 Prognosys Biosciences, Inc. Procédés et systèmes pour déterminer des motifs spatiales de cibles biologiques dans un échantillon
WO2015070037A2 (fr) 2013-11-08 2015-05-14 Prognosys Biosciences, Inc. Conjugués de polynucléotides et procédés de détection d'analytes
JP6828007B2 (ja) 2015-04-10 2021-02-10 スペーシャル トランスクリプトミクス アクチボラグ 生物学的試料の空間識別されるマルチプレックスな核酸分析
WO2016191430A1 (fr) 2015-05-28 2016-12-01 Marrone Bio Innovations, Inc. Utilisation de protéines pour lutter contre les mollusques
WO2016210350A1 (fr) * 2015-06-25 2016-12-29 Amyris, Inc. Dégrons dépendant du maltose, promoteurs sensibles au maltose, constructions de stabilisation, et leur utilisation dans la production de composés non cataboliques
CN117051017A (zh) 2018-09-25 2023-11-14 孟山都技术公司 新型昆虫抑制性蛋白
TW202205956A (zh) 2020-05-01 2022-02-16 美商韋斯塔隆公司 殺蟲組合

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670367A (en) * 1991-08-26 1997-09-23 Immuno Aktiengesellschaft Recombinant fowlpox virus
WO1999042589A2 (fr) * 1998-02-20 1999-08-26 Novartis Pharma Ag. Toxines insecticides de photorhabdus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670367A (en) * 1991-08-26 1997-09-23 Immuno Aktiengesellschaft Recombinant fowlpox virus
WO1999042589A2 (fr) * 1998-02-20 1999-08-26 Novartis Pharma Ag. Toxines insecticides de photorhabdus

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 23 November 1989 (1989-11-23), XP002243473, Database accession no. X16664; AF301153; AF302690 *
DATABASE SWISSPROT [online] 1 November 1996 (1996-11-01), XP002243474, Database accession no. Q57460 *
DATABASE WPI Section Ch Week 199944, Derwent World Patents Index; Class B04, AN 1999-527479, XP002243475 *

Also Published As

Publication number Publication date
AU2002339119A1 (en) 2002-12-03
EP1379549A2 (fr) 2004-01-14
CA2434323A1 (fr) 2002-11-28
WO2002094867A2 (fr) 2002-11-28
KR20030085528A (ko) 2003-11-05
WO2002094867A8 (fr) 2003-01-23
US20070020625A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
WO2002094867A3 (fr) Sequence du genome de photorhabdus luminescens souche tto1 et utilisations
WO2004029220A3 (fr) Genes artificiels
WO2002057664A3 (fr) Nouvelles proteines insecticides du bacillus thuringiensis
AU6724194A (en) Nucleotide sequences for the control of the expression of dna sequences in a cellular host
AU2002348411A1 (en) Elastomeric articles having improved chemical resistance
EP1288298A3 (fr) Synthétases-tRNA de Staphylococcus Aureus
HK1045326A1 (zh) 微生物的β-葡萄糖甘酸酶基因，基因產品及其用法
WO2003050260A3 (fr) Fusions de genes exprimees par la streptavidine et leurs procedes d'utilisation
AU5906699A (en) (neisseria spp.) polypeptide, nucleic acid sequence and uses thereof
GB0205378D0 (en) Bacterial spores
WO2002033057A3 (fr) Mono-oxygenases de type cytochrome p450 constituees de bacteries thermophiles
WO2004020640A3 (fr) Cassettes d'expression procaryotes regulees par le zinc
CA2285633A1 (fr) Plasmides bacteriens
WO2001077365A3 (fr) Procedes et materiaux antimicrobiens
WO2001009164A3 (fr) Proteines de replication de l'adn de bacteries gram-positif et leur utilisation dans l'identification par criblage d'inhibiteurs chimiques
WO2000039323A3 (fr) Production de proteines dans des micro-organismes gram-positif
CA2378537A1 (fr) Proteine de chlamysine b antibacterienne, gene codant pour cette proteine et systeme d'expression destines a cette proteine.
AU2001287682A1 (en) Nucleotide sequences coding for the ftsx gene
WO2000008145A3 (fr) Nouveaux genes de regulation de l'hematopoiese
WO2002046378A3 (fr) Sequence amino-acide et nucleotidique pol k de substitution et procedes d'utilisation
WO1995015383A3 (fr) Agents de lutte biologique
AU2003260539A1 (en) Anti-bacterial peptides, genes coding for peptides, transformed organisms, vectors, preparation thereof and compositions containing same
WO2002002629A3 (fr) Proteines de liaison grf2 et utilisations de celles-ci
WO2002088168A3 (fr) Acide nucleique
WO2004052925A3 (fr) Genes de virulence bacterienne

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 48/2002 ADD "DECLARATION UNDER RULE 4.17: - OF INVENTORSHIP (RULE 4.17(IV) FOR US ONLY."

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2434323

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002751498

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020037010403

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1020037010403

Country of ref document: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002751498

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007020625

Country of ref document: US

Ref document number: 10467478

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2002751498

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 10467478

Country of ref document: US